Covidien plc 4
4 · Covidien plc · Filed Dec 9, 2013
Insider Transaction Report
Form 4
Covidien plcCOV
Masterson John H
SVP and General Counsel
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2013-12-09−10,734→ 21,468 totalExercise: $42.39Exp: 2021-11-30→ Ordinary Shares (10,734 underlying) - Exercise/Conversion
Ordinary Shares
2013-12-09$39.18/sh+15,192$595,223→ 87,399 total - Sale
Ordinary Shares
2013-12-09$68.51/sh−38,093$2,609,774→ 72,207 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-12-09−15,192→ 15,192 totalExercise: $39.18Exp: 2020-11-30→ Ordinary Shares (15,192 underlying) - Exercise/Conversion
Ordinary Shares
2013-12-09$43.44/sh+12,167$528,534→ 99,566 total - Exercise/Conversion
Ordinary Shares
2013-12-09$42.39/sh+10,734$455,014→ 110,300 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-12-09−12,167→ 0 totalExercise: $43.44Exp: 2019-11-30→ Ordinary Shares (12,167 underlying)
Footnotes (2)
- [F1]The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $68.50 to $68.59 The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
- [F2]Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.